| Trial ID: | L0278 |
| Source ID: | NCT01003275
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Metabolic Effects of Paricalcitol
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01003275/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Paricalcitol|DRUG: Placebo
|
| Outcome Measures: |
Primary: Glucose Area Under the Curve (AUC), Glucose AUC during a 2-hour oral glucose tolerance test, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of Washington | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-10
|
| Completion Date: |
2011-11
|
| Results First Posted: |
2013-09-27
|
| Last Update Posted: |
2014-04-28
|
| Locations: |
University of Washington, Seattle, Washington, 98195, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01003275
|
